Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

User Fee Talks On Schedule And Making Progress, Industry Says

This article was originally published in The Gray Sheet

Executive Summary

Despite FDA warnings that time is running out for an agreement to be reached with industry on a user fee reauthorization plan, device industry leaders say the two sides have made “good progress” toward reaching a pact.

You may also be interested in...



FDA Gives Details On New Reviewer Training Program

FDA is hoping a center-wide training program for all new reviewers, launched this month, will improve the consistency of medical device pre-market reviews.

FDA Wary Of Industry’s New Pre-Market Review Goal Proposals

Recent device industry proposals for more aggressive pre-market review goals could result in fewer device clearances and approvals, FDA warns.

Corindus Envisions Network Of CorPath Robots For Remote Neurovascular And Coronary Interventions

The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.

Topics

UsernamePublicRestriction

Register

MT030599

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel